HRHélène Raoult

Hélène Raoult

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hélène Raoult has a total of 137 co-authors. Here are the top co-authors by number of shared publications:

  • Jean-Christophe Ferré

    Univ Rennes, CHU Rennes, (Service de radiologie et imagerie médicale) Rennes France

    11 shared publications
  • Jean-Yves Gauvrit

    Department of Neuroradiology, Regional University Hospital, Rennes, France

    7 shared publications
  • Francois Eugene

    Department of radiology, Rennes University Medical Center, Rennes, France

    5 shared publications
  • Romain Bourcier

    11Department of Neuroradiology, Regional University Hospital, Nantes, France

    4 shared publications
  • Aymeric Stamm

    3 shared publications
  • Christian Barillot

    From the CHU Rennes, Department of Neuroradiology, Rennes, France (H.R., J.-C.F., J.-Y.G.); Unité VISAGES U746 INSERM-INRIA, IRISA UMR CNRS 6074, University of Rennes, Rennes, France (H.R., E.B., P.M., C.N., J.-C.F., C.B., J.-Y.G); and MR Application & Workflow Development, Siemens AG, Healthcare Sector, Erlangen, Germany (P.S.).

    3 shared publications

Latest Publications

  • Angio-RM morphologique et dynamique sans injection de contraste dans l'exploration des pathologies neurovasculaires à l'étage cervical et encéphalique

    by Hélène Raoult

    L’angio-RM est l’imagerie de choix pour l’exploration non invasive des pathologies neurovasculaires. Le développement de nouvelles séquences d’ARM sans injection, combinant des techniques d’acquisition innovantes tel l’arterial spin labeling au haut champ magnétique et à l’imagerie parallèle, laisse présager la perspective de résolutions spatiales et temporelles extrêmement intéressantes en des temps d’acquisition courts. Ces nouvelles séquences seraient ainsi une alternative avantageuse aux séquences habituelles et à l’imagerie de référence invasive qu’est l’artériographie. Nous nous sommes intéressés à l’optimisation de l’acquisition et du post-traitement de nouvelles séquences d’ARM sans injection dans deux contextes pathologiques particuliers, choisis de par leur pertinence en termes d’enjeu clinique et radiologique : la sténose carotidienne cervicale et la malformation artério-veineuse (MAV) encéphalique. La séquence « unenhanced carotid MRA » à l’étage cervical a été optimisée avec une lecture préférentielle du centre de l’espace k, une résolution spatiale isotropique et inframillimétrique, un temps d’acquisition de moins de 3 minutes, et un large volume couvert, sans la contrainte d’une synchronisation cardiaque. Elle a montré une qualité d’image supérieure au TOF grâce à une amélioration de l’homogénéité du signal intravasculaire et à une diminution des artéfacts de flux, avec une intensité de signal et un contraste artère/tissus supérieurs. Elle permettait une détection et une quantification précise des sténoses carotidiennes bulbaires chez les patients en comparaison avec l’angioscanner et permettait également de détecter les lésions infrapétreuses. Les perspectives sont d’améliorer le signal et le volume couvert pour proposer une séquence de dépistage rapide et synchrone des sténoses cervicales et encéphaliques. La séquence « 4D-SL MRA » à l’étage encéphalique a été optimisée avec un marquage de type IR-STAR et une série parabolique d'angles de bascule, une résolution temporelle inférieure à 70 ms et une fenêtre d’acquisition permettant d’analyser le drainage veineux en un temps d’acquisition de 7 minutes. Elle a permis une analyse fiable de l’angioarchitecture des MAV en comparaison avec l’artériographie et offre une délimitation précise du nidus, suggérant son intérêt pour l’évaluation du risque hémorragique et la décision thérapeutique. Un post-traitement dédié développé sous Matlab et SPM8 a permis d’améliorer la visualisation de l’arbre vasculaire et d’accéder à une quantification des paramètres hémodynamiques au sein de la MAV. Ainsi un ratio de « temps-au-pic-de signal » artériel/veineux bas apparaissait corrélé avec le risque de rupture des MAV. L’ARM 4D-SL pourrait permettre de tendre vers une nouvelle classification des MAVs, intégrant des paramètres hémodynamiques intra-MAV et des paramètres perfusionnels et microstructurels du parenchyme environnant, afin de proposer une prise en charge individualisée des patients.

  • Open Access

    CLinical Assessment of WEB device in Ruptured aneurYSms (CLARYS): 12-month angiographic results of a multicenter study

    by Laurent Spelle, Denis Herbreteau, Jildaz Caroff, Xavier Barreau, Jean-Christophe Ferré, Jens Fiehler, Anne-Christine Januel, Vincent Costalat, Thomas Liebig, Romain Bourcier, et al.

    Background The CLinical Assessment of WEB device in Ruptured aneurYSms (CLARYS) study has shown that the endovascular treatment of ruptured bifurcation aneurysms with the Woven EndoBridge (WEB) is safe and effective and provides protection against rebleeding at 1 month and 1 year. The 12-month angiographic follow-up is an important endpoint of the study. Methods The CLARYS study is a prospective multicenter study conducted in 13 European centers. The study enrolled 60 patients with 60 ruptured aneurysms of the anterior and posterior circulation. The study was conducted with an independent assessment of safety outcomes and imaging. Results Sixty patients with 60 ruptured bifurcation aneurysms to be treated with the WEB were included. Fifty-three aneurysms (88.3%) had a broad base with a dome to neck ratio Conclusions The CLARYS study has previously shown that the use of the WEB in the endovascular treatment of ruptured bifurcation aneurysms provides effective protection against rebleeding with a good safety profile. The angiographic occlusion rates at 1 year reported here are comparable to those already seen in previous multicenter studies which primarily included unruptured aneurysms.


  • Open Access

    CLinical Assessment of WEB device in Ruptured aneurYSms (CLARYS): results of 1-month and 1-year assessment of rebleeding protection and clinical safety in a multicenter study

    by Laurent Spelle, Denis Herbreteau, Jildaz Caroff, Xavier Barreau, Jean-Christophe Ferré, Jens Fiehler, Anne-Christine Januel, Vincent Costalat, Thomas Liebig, Romain Bourcier, et al.

    Background The primary goal of the CLARYS study is to assess the protection against rebleeding when treating ruptured bifurcation aneurysms with the Woven EndoBridge (WEB) device. Methods The CLARYS study is a prospective, multicenter study conducted in 13 European centers. Patients with ruptured bifurcation aneurysms were consecutively included between February 2016 and September 2017. The primary endpoint was defined as the rebleeding rate of the target aneurysm treated with the WEB within 30 days postprocedure. Secondary endpoints included periprocedural and postprocedural adverse events, total procedure and fluoroscopy times, and modified Rankin Scale score at 1 month and 1 year. Results Sixty patients with 60 ruptured bifurcation aneurysms to be treated with the WEB were included. A WEB device was successfully implanted in 93.3%. The rebleeding rate at 1 month and 1 year was 0%. The mean fluoroscopy time was 27.0 min. Twenty-three periprocedural complications were observed in 18 patients and resolved without sequelae in 16 patients. Two of these complications were attributed to the procedure and/or the use of the WEB, leading to a procedure/device-related intraoperative complication rate of 3.3%. Overall mortality at 1 month and 1 year was 1.7% and 3.8%, respectively and overall morbidity at 1 month and 1 year was 15% and 9.6%, respectively. WEB-related 1-month and 1-year morbidity and mortality was 0%. Conclusions The interim results of CLARYS show that the endovascular treatment of ruptured bifurcation aneurysms with the WEB is safe and effective and, in particular, provides effective protection against rebleeding. It may induce profound change in the endovascular management of ruptured bifurcation aneurysms.


  • DWI-Based Algorithm to Predict Disability in Patients Treated with Thrombectomy for Acute Stroke

    by H. Raoult, M.V. Lassalle, B. Parat, C. Rousseau, F. Eugène, S. Vannier, S. Evain, A. Le Bras, T. Ronziere, J.C. Ferre, et al.

    BACKGROUND AND PURPOSE: The reasons for poor clinical outcome after thrombectomy for acute stroke, concerning around half of all patients, are misunderstood. We developed a hierarchic algorithm based on DWI to better identify patients at high risk of disability. MATERIALS AND METHODS: Our single-center, retrospective study included consecutive patients with acute ischemic stroke who underwent thrombectomy for large anterior artery occlusion and underwent pretreatment DWI. The primary outcome was the mRS at 3 months after stroke onset. Multivariable regression was used to identify independent clinical and imaging predictors of poor prognosis (mRS > 2) at 3 months, and a hierarchic algorithm predictive of disability was developed. RESULTS: A total of 149 patients were analyzed. In decreasing importance, DWI lesion volume of >80 mL, baseline NIHSS score of >14, age older than 75 years, and time from stroke onset to groin puncture of >4 hours were independent predictors of poor prognosis. The predictive hierarchic algorithm developed from the multivariate analysis predicted the risk of disability at 3 months for up to 100% of patients with a high predictive value. The area under the receiver operating characteristic curve was 0.87. CONCLUSIONS: The DWI-based hierarchic algorithm we developed is highly predictive of disability at 3 months after thrombectomy and is easy to use in routine practice.


  • CT angiography for one-year follow-up of intracranial aneurysms treated with the WEB device: Utility in evaluating aneurysm occlusion and WEB compression at one year

    by Hélène Raoult, François Eugène, Anthony Le Bras, Géraldine Mineur, Béatrice Carsin-Nicol, Jean-Christophe Ferré, Jean-Yves Gauvrit


  • Inter- and intraobserver reliability for angiographic leptomeningeal collateral flow assessment by the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) scale

    by Wagih Ben Hassen, Claire Malley, Grégoire Boulouis, Frédéric Clarençon, Bruno Bartolini, Romain Bourcier, Christine Rodriguez Régent, Nicolas Bricout, Marc Antoine Labeyrie, Jean Christophe Gentric, et al.

    Background: The adequacy of leptomeningeal collateral flow has a pivotal role in determining clinical outcome in acute ischemic stroke. The American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) collateral score is among the most commonly used scales for measuring this flow. It is based on the extent and rate of retrograde collateral flow to the impaired territory on angiography.Objective: To evaluate inter- and intraobserver agreementin angiographic leptomeningeal collateral flow assessment.Materials and methods: Thirty pretreatment angiogram video loops (frontal and lateral view), chosen from the randomized controlled trial THRombectomie des Artères CErebrales (THRACE), were sent for grading in an electronic file. 19 readers participated, including eight who had access to a training set before the first grading. 13 readers made a double evaluation, 3 months apart.Results: Overall agreement among the 19 observers was poor (κ = 0,16 ± 6,5.10-3), and not improved with prior training (κ = 0,14 ± 0,016). Grade 4 showed the poorest interobserver agreement (κ=0.18±0.002) while grades 0 and 1 were associated with the best results (κ=0.52±0.001 and κ=0.43±0.004, respectively). Interobserver agreement increased (κ = 0,27± 0,014) when a dichotomized score, ‘poor collaterals’ (score of 0, 1 or 2) versus ‘good collaterals’ (score of 3 or 4) was used. The intraobserver agreements varied between slight (κ=0.18±0.13) and substantial (κ=0.74±0.1), and were slightly improved with the dichotomized score (from κ=0.19±0.2 to κ=0.79±0.11).Conclusion: Inter- and intraobserver agreement of collateral circulation grading using the ASITN/SIR score was poor, raising concerns about comparisons among publications. A simplified dichotomized judgment may be a more reproducible assessment when images are rated by the same observer(s) in randomized trials.


  • Multicenter initial experience with the EmboTrap device in acute anterior ischemic stroke

    by R. Bourcier, D. Abed, M. Piotin, H. Redjem, J.C. Ferré, F. Eugène, H. Raoult, M. Mirza, R. Chapot, H. Desal, et al.


  • Open Access

    Revised CT angiography venous score with consideration of infratentorial circulation value for diagnosing brain death

    by Antoine J. Marchand, Philippe Seguin, Yannick Malledant, Marion Taleb, Hélène Raoult, Jean Yves Gauvrit


  • Mechanical thrombectomy with the ERIC retrieval device: initial experience

    by Hélène Raoult, Hocine Redjem, Romain Bourcier, Alina Gaultier-Lintia, Benjamin Daumas-Duport, Jean-Christophe Ferré, François Eugène, Robert Fahed, Bruno Bartolini, Michel Piotin, et al.

    Objective To report our experience with the Embolus Retriever with Interlinked Cage (ERIC) stentriever for use in mechanical endovascular thrombectomy (MET). Methods Thirty-four consecutive patients with acute stroke (21 men and 13 women; median age 66 years) determined appropriate for MET were treated with ERIC and prospectively included over a 6-month period at three different centers. The ERIC device differs from typical stentrievers in that it is designed with a series of interlinked adjustable nitinol cages that allow for fast thrombus capture, integration, and withdrawal. The evaluated endpoints were successful revascularization (Thrombolysis in Cerebral Infarction (TICI) 2b–3) and good clinical outcomes at 3 months (modified Rankin Scale (mRS) 0–2). Results Locations of the occlusions included the middle cerebral artery (13 patients), terminal carotid artery (11 patients), basilar artery (1 patient), and tandem occlusions (9 patients). IV thrombolysis was performed in 20/34 (58.8%) patients. Median times from symptom onset to recanalization and from puncture to recanalization were 325.5 min (180–557) and 78.5 min (14–183), respectively. Used as the first-line device, ERIC achieved a successful recanalization in 20/24 (83.3%) patients. Successful recanalization was associated with lower National Institutes of Health Stroke Scale scores at 24 h (8±6.5 vs 21.5±2.1; p=0.008) and lower mRS at 3 months (2.7±2.1 vs 5.3±1.1; p=0.04). Three procedural complications and four asymptomatic hemorrhages were recorded. Good clinical outcomes at 3 months were seen in 15/31 (48.4%) patients. Conclusions The ERIC device is an innovative stentriever allowing fast, effective, and safe MET.


  • Open Access

    Inter- and Intrarater Agreement on the Outcome of Endovascular Treatment of Aneurysms Using MRA

    by S. Jamali, R. Fahed, J.- C. Gentric, L. Letourneau-Guillon, H. Raoult, F. Bing, L. Estrade, T. N. Nguyen, E. Tollard, J.- C. Ferre, et al.

    BACKGROUND AND PURPOSE: Patients treated with coiling are often followed by MR angiography. Our objective was to assess the inter- and intraobserver agreement in diagnosing aneurysm remnants and recurrences by using multimodality imaging, including TOF MRA. MATERIALS AND METHODS: A portfolio composed of 120 selected images from 56 patients was sent to 15 neuroradiologists from 10 institutions. For each case, raters were asked to classify angiographic results (3 classes) of 2 studies (32 MRA-MRA and 24 DSA-MRA pairs) and to provide a final judgment regarding the presence of a recurrence (no, minor, major). Six raters were asked to independently review the portfolio twice. A second study, restricted to 4 raters having full access to all images, was designed to validate the results of the electronic survey. RESULTS: The proportion of cases judged to have a major recurrence varied between 16.1% and 71.4% (mean, 35.0% ± 12.7%). There was moderate agreement overall (κ = 0.474 ± 0.009), increasing to nearly substantial (κ = 0.581 ± 0.014) when the judgment was dichotomized (presence or absence of a major recurrence). Agreement on cases followed-up by MRA-MRA was similarly substantial (κ = 0.601 ± 0.018). The intrarater agreement varied between fair (κ = 0.257 ± 0.093) and substantial (κ= 0.699 ± 0.084), improving with a dichotomized judgment concerning MRA-MRA comparisons. Agreement was no better when raters had access to all images. CONCLUSIONS: There is an important variability in the assessment of angiographic outcomes of endovascular treatments. Agreement on the presence of a major recurrence when comparing 2 MRA studies or the MRA with the last catheter angiographic study can be substantial.